The CYP3A4* 1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer

Pharmacogenetics

Volumn 12, Issue 5, 2002, Pages 355-366

  Spurdle, Amanda B ^a   Goodwin, Bryan ^a   Hodgson, Ecushla ^a   Hopper, John L ^a   Chen, Xiaoqing ^a   Purdie, David M ^a   McCredie, Margaret R E ^a   Giles, Graham G ^a   Chenevix Trench, Georgia ^a   Liddle, Christopher ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Breast cancer; CYP3A4; Ovarian cancer; Polymorphism

Indexed keywords

CYTOCHROME P450 3A4; STEROID HORMONE; CYP3A PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450; PRIMER DNA;

5' UNTRANSLATED REGION; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE CONSTRUCT; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN TISSUE; LIVER CELL; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; AUSTRALIA; BREAST TUMOR; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS; INTERVIEW; NUCLEOTIDE SEQUENCE; OVARY TUMOR; QUESTIONNAIRE; RESTRICTION MAPPING; RISK FACTOR;

5' UNTRANSLATED REGIONS; ADULT; AUSTRALIA; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; INTERVIEWS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; QUESTIONNAIRES; RESTRICTION MAPPING; RISK FACTORS;

EID: 0036020978     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200207000-00003     Document Type: Article

References (48)

1. CYP3A gene expression in human gut epithelium
2. Expression of cytochromes P450 in human breast tissue and tumors
3. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae
4. Human liver microsomal steroid metabolism: Identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme
5. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s
6. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes
7. Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s
8. Oxidation of 17α-ethynylestradiol by human liver cytochrome P-450
9. The CYP3 family
10. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4
11. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver
12. Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients
13. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients
14. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
15. Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control
16. Response: Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
17. Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
18. Population distribution and effects on drug metabolism of a genetic variant in the 5′ promoter region of CYP3A4
19. Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients
20. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: Ethnic distribution and implications for prostate cancer risk. Mutations in brief no. 191. Online
21. Interindividual differences in hepatic expression of CYP3A4: Relationship to genetic polymorphism in the 5′-upstream regulatory region
22. Association of CYP3A4 genotype with treatment-related leukemia
23. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
24. CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4* 1B 5′- promoter region polymorphism
25. Hormonal aspects of epithelial ovarian cancer: Review of epidemiological evidence
26. Endogenous hormones and breast cancer risk
27. Functional role of estrogen metabolism in target cells: Review and perspectives
28. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module
29. Background, rationale and protocol for a case-control-family study of breast cancer
30. Breast cancer in Australian women under the age of 40
31. Design and analysis issues in a population-based case-control-family study of the genetic epidemiology of breast cancer and the Cooperative Family Registry for Breast Cancer Studies (CFRBCS)
32. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2
33. BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer
34. Reproductive and other factors and risk of epithelial ovarian cancer: An Australian case-control study
35. The microsomal epoxide hydrolase Tyr1 13His polymorphism: Association with risk of ovarian cancer
36. CYP17 promotor polymorphism and ovarian cancer risk
37. Genetic and environmental contributions to alcohol dependence risk in a national twin sample: Consistency of findings in women and men
38. Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty
39. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer
40. Preparation of isolated rat liver cells
41. Phenotypic stability of adult rat hepatocytes in primary monolayer culture
42. Electroporation-mediated gene transfer into hepatocytes
43. Electroporation-mediated gene transfer into hepatocytes: Preservation of a growth hormone response
44. Protein measurement with the Folin-phenol reagent
45. The putative high activity variant, CYP3A4* 1B, predicts the onset of puberty in young girls
46. Polymorphism of enzymes involved in drug metabolism: Gene structure and enzymatic activity
47. Different regulation and expression of the human CYP2E1 gene due to the Rsal polymorphism in the 5′-flanking region
48. Recent advances in understanding the molecular basis of polymorphisms in genes encoding cytochrome P450 enzymes